Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Oct. 3)

In this week’s View, Dr. Eagle discusses the Fitbit Heart Study that examines the detection of atrial fibrillation in a large population using wearable devices, then looks at the long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention. Finally, Dr. Eagle discusses risk assessment of hypertensive events during pregnancy.

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Stable Ischemic Heart Disease, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Interventions and Imaging, Interventions and Vascular Medicine, Echocardiography/Ultrasound, Hypertension, Chronic Angina

Keywords: EaglesEyeView, Photoplethysmography, Atrial Fibrillation, Smartphone, Fitness Trackers, Electrocardiography, Wearable Electronic Devices, Echocardiography, Pregnancy Trimester, First, Hypertension, Pregnancy-Induced, Blood Pressure, Antihypertensive Agents, Arterial Pressure, Platelet Aggregation Inhibitors, Heparin, Low-Molecular-Weight, Warfarin, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Stroke Volume, Cardiomyopathy, Dilated, Embolic Stroke, Fibrinolysis, Myocarditis, Takotsubo Cardiomyopathy, Thrombosis

< Back to Listings